Mylotarg™ (gemtuzumab ozogamicin)
for Leukemia

Mylotarg (gemtuzumab ozogamicin) is a monoclonal antibody combined with chemotherapy, designed to target and kill CD33-positive leukemia cells while sparing healthy ones. It treats newly-diagnosed CD33-positive acute myeloid leukemia (AML) in adults and children (≥1 month), and relapsed or refractory AML in patients aged 2 years and older.

Heart
Medication Guide Icon Medication Guide
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Leukemia